Chim AM - Search Results

1

Targeted hepatitis C screening among ex-injection drug users in the community.

Wong VW, Wong GL, Chim AM, Cheng TF, Cheung SW, Lai CM, Szeto KJ, Tsang S, Wu SH, Yan KK, Hui AY, Yiu DC, Wu BB, Cheung D, Chung CS, Lai CW, Chan HL. Wong VW, et al. Among authors: chim am. J Gastroenterol Hepatol. 2014 Jan;29(1):116-20. doi: 10.1111/jgh.12355. J Gastroenterol Hepatol. 2014. PMID: 24033786

2

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment.

Chan HL, Wong ML, Hui AY, Chim AM, Tse AM, Hung LC, Chan FK, Sung JJ. Chan HL, et al. Among authors: chim am. World J Gastroenterol. 2003 Dec;9(12):2695-7. doi: 10.3748/wjg.v9.i12.2695. World J Gastroenterol. 2003. PMID: 14669315 Free PMC article. Clinical Trial.

3

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.

Hui AY, Liew CT, Go MY, Chim AM, Chan HL, Leung NW, Sung JJ. Hui AY, et al. Among authors: chim am. Liver Int. 2004 Dec;24(6):611-8. doi: 10.1111/j.1478-3231.2004.0957.x. Liver Int. 2004. PMID: 15566512

4

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ. Chan HL, et al. Among authors: chim am. Ann Intern Med. 2005 Feb 15;142(4):240-50. doi: 10.7326/0003-4819-142-4-200502150-00006. Ann Intern Med. 2005. PMID: 15710957 Clinical Trial.

5

Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.

Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ. Hui AY, et al. Among authors: chim am. Am J Gastroenterol. 2005 Mar;100(3):616-23. doi: 10.1111/j.1572-0241.2005.41289.x. Am J Gastroenterol. 2005. PMID: 15743360

6

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.

Chan HL, Hui AY, Wong VW, Chim AM, Wong ML, Sung JJ. Chan HL, et al. Among authors: chim am. Hepatology. 2005 Jun;41(6):1357-64. doi: 10.1002/hep.20695. Hepatology. 2005. PMID: 15880608 Clinical Trial.

7

Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.

Chan HL, Wang H, Niu J, Chim AM, Sung JJ. Chan HL, et al. Among authors: chim am. Antivir Ther. 2007;12(3):345-53. Antivir Ther. 2007. PMID: 17591024 Clinical Trial.

8

Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B.

Chan HL, Wong VW, Chim AM, Choi PC, Chan HY, Hui AY, Wong GL, Sung JJ. Chan HL, et al. Among authors: chim am. Antivir Ther. 2007;12(5):815-23. Antivir Ther. 2007. PMID: 17713165 Clinical Trial.

9

Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.

Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL. Wong VW, et al. Among authors: chim am. Liver Transpl. 2007 Sep;13(9):1228-35. doi: 10.1002/lt.21222. Liver Transpl. 2007. PMID: 17763399 Free article.

10

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, Wong GL, Sung JJ. Chan HL, et al. Among authors: chim am. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8. doi: 10.1016/j.cgh.2007.09.005. Clin Gastroenterol Hepatol. 2007. PMID: 18054753 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters